Kadin ME - Search Results

1

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies.

Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M, Younes A. Snell V, et al. Among authors: kadin me. Br J Haematol. 1997 Dec;99(3):618-24. doi: 10.1046/j.1365-2141.1997.4393250.x. Br J Haematol. 1997. PMID: 9401075 Free article.

2

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A. Gruss HJ, et al. Among authors: kadin me. Am J Pathol. 1996 Aug;149(2):469-81. Am J Pathol. 1996. PMID: 8701986 Free PMC article.

3

The t(2;5) in human lymphomas.

Kadin ME, Morris SW. Kadin ME, et al. Leuk Lymphoma. 1998 Apr;29(3-4):249-56. doi: 10.3109/10428199809068562. Leuk Lymphoma. 1998. PMID: 9684923 Review.

4

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.

Younes A, Kadin ME. Younes A, et al. Among authors: kadin me. J Clin Oncol. 2003 Sep 15;21(18):3526-34. doi: 10.1200/JCO.2003.09.037. J Clin Oncol. 2003. PMID: 12972530 Review.

5

Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.

Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW. Kadin ME, et al. Am J Surg Pathol. 2008 Sep;32(9):1421-6. doi: 10.1097/PAS.0b013e3181648d6d. Am J Surg Pathol. 2008. PMID: 18670345

6

Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.

Terenzi A, Bolognesi A, Pasqualucci L, Flenghi L, Pileri S, Stein H, Kadin M, Bigerna B, Polito L, Tazzari PL, Martelli MF, Stirpe F, Falini B. Terenzi A, et al. Br J Haematol. 1996 Mar;92(4):872-9. doi: 10.1046/j.1365-2141.1995.404942.x. Br J Haematol. 1996. PMID: 8616080

7

Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.

Braun FK, Hirsch B, Al-Yacoub N, Dürkop H, Assaf C, Kadin ME, Sterry W, Eberle J. Braun FK, et al. Among authors: kadin me. J Invest Dermatol. 2010 Mar;130(3):826-40. doi: 10.1038/jid.2009.299. Epub 2009 Nov 5. J Invest Dermatol. 2010. PMID: 19890350 Free article.

8

Pure red cell aplasia: lymphocyte inhibition of erythropoiesis.

Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Abkowitz JL, et al. Among authors: kadin me. Br J Haematol. 1986 May;63(1):59-67. doi: 10.1111/j.1365-2141.1986.tb07495.x. Br J Haematol. 1986. PMID: 3085703

9

Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.

Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M, Watanabe T. Horie R, et al. Am J Pathol. 2002 May;160(5):1647-54. doi: 10.1016/S0002-9440(10)61112-1. Am J Pathol. 2002. PMID: 12000717 Free PMC article.

10

Pathology of malignant lymphomas.

Kadin ME, Said JW. Kadin ME, et al. Curr Opin Oncol. 1990 Oct;2(5):822-31. doi: 10.1097/00001622-199010000-00004. Curr Opin Oncol. 1990. PMID: 1965694 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page